Page 9 - Presection News Today

Opinion granted based on positive results from the Phase 3 KEYNOTE-716 trial If approved, KEYTRUDA would be the first anti-PD-1 immunotherapy treatment option for patients 12 years and older in

Topical imiquimod offers an alternative to surgery for women with HPV-related precancerous lesions, concludes the first head-to-head randomized trial of the two approaches.

The American Society for Radiation Oncology (ASTRO) has issued new recommendations on radiotherapy treatment in patients with brain metastases, which updates the last guidelines issued in 2012.

The TINYPOLYP trial finds cold forceps polypectomy noninferior to cold snare polypectomy for complete resection of nonpedunculated polyps measuring 3 mm or less.

Dr Nancy Reau speaks with HCC expert Dr Amit Singal on how these 11 new recommendations may change how you approach this increasingly common cancer.

Most notably, the team found that frailty had no effect on surgical outcomes. The study was published as a preprint and has not yet been peer reviewed.

The inframammary breast-conserving approach for deep-seated tumors led to acceptable cosmetic results in 82% of cases. The study was published as a preprint and has not yet been peer reviewed.

Several studies in lung cancer have started enrolling recently ― maybe one of your patients could benefit.

A new analysis found that "Black patients are less likely than White patients to receive standard of care" when undergoing surgery to treat gastrointestinal tract cancer.

Further data from the pivotal Checkmate 816 trial continue to support the combination of nivolumab with chemotherapy in the neoadjuvant setting for patients with resectable non–small cell lung cancer.